(0.19%) 5 141.00 points
(0.16%) 38 503 points
(0.27%) 17 893 points
(-0.91%) $83.09
(1.66%) $1.955
(-0.20%) $2 342.50
(0.91%) $27.50
(0.23%) $924.20
(-0.17%) $0.933
(-0.14%) $11.01
(-0.23%) $0.799
(1.18%) $92.96
Live Chart Being Loaded With Signals
Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments...
Stats | |
---|---|
今日成交量 | 14 462.00 |
平均成交量 | 128 693 |
市值 | 1.79B |
EPS | SEK0.0500 ( 2023-11-15 ) |
下一个收益日期 | ( SEK0 ) 2024-05-15 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 29.04 |
ATR14 | SEK0.0980 (0.36%) |
音量 相关性
Genovis AB (publ.) 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Genovis AB (publ.) 相关性 - 货币/商品
Genovis AB (publ.) 财务报表
Annual | 2023 |
营收: | SEK158.23M |
毛利润: | SEK54.00M (34.13 %) |
EPS: | SEK0.940 |
FY | 2023 |
营收: | SEK158.23M |
毛利润: | SEK54.00M (34.13 %) |
EPS: | SEK0.940 |
FY | 2022 |
营收: | SEK102.39M |
毛利润: | SEK87.37M (85.33 %) |
EPS: | SEK0.170 |
FY | 2021 |
营收: | SEK93.02M |
毛利润: | SEK81.29M (87.39 %) |
EPS: | SEK0.378 |
Financial Reports:
No articles found.
Genovis AB (publ.)
Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; and GingisKHAN, a cysteine protease that digests human IgG1 at a specific site above the hinge. In addition, the company offers GingisREX, a cysteine protease that specifically digests peptide bonds C-terminally to arginine residues; and IgGZERO (EndoS), an endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes N-linked glycans in the Fc-region of native IgG. Further, it provides IgGZERO LE, an endoglycosidase acting on complex type N-glycans from Streptococcus pyogenes; deGlycIT, an IgGZERO (EndoS) enzyme for agarose beads for deglycosylation of Fc-glycans; GlycINATOR an endoglycosidase from Streptococcus pyogenes that hydrolyzes the all glycoforms structure; and GlycINATOR (EndoS2), an endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes glycans at the Fc glycosylation site of IgG. Additionally, the company offers GlyCLICK, a site-specific conjugation technology used for IgG on enzymatic remodeling of the Fc glycans and click chemistry; SialEXO, a sialidase product for the removal and analysis of sialic acids; enzymes for O-glycans; and antibody fragmentation services, as well as operates online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Sweden, Europe, North America, and Asia. The company has a collaboration with Waters Corporation. Genovis AB (publ.) was founded in 1999 and is based in Lund, Sweden.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。